Pages that link to "Q45939260"
Jump to navigation
Jump to search
The following pages link to Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. (Q45939260):
Displaying 30 items.
- Lipid-lowering efficacy of atorvastatin (Q24187301) (← links)
- Lipid lowering efficacy of atorvastatin (Q24202363) (← links)
- The stats are in: an update on statin use in COPD (Q26778906) (← links)
- Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes (Q26853571) (← links)
- Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial (Q28742007) (← links)
- Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. (Q33824051) (← links)
- Effects of atorvastatin on human C-reactive protein metabolism. (Q33848035) (← links)
- Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE III for coronary heart disease patients (Q34266187) (← links)
- Effects of high versus low-dose atorvastatin on high sensitive C-reactive protein in acute coronary syndrome (Q34675610) (← links)
- Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers (Q34756897) (← links)
- High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome (Q35608066) (← links)
- Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants (Q35918786) (← links)
- Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia (Q36054829) (← links)
- Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study (Q37732587) (← links)
- YKL-40: a new biomarker in cardiovascular disease? (Q37779310) (← links)
- Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? (Q37941943) (← links)
- Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism (Q38741861) (← links)
- Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia (Q40504034) (← links)
- Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy (Q42686418) (← links)
- Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies (Q42700712) (← links)
- Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart disease (Q43274882) (← links)
- Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia (Q45345113) (← links)
- Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis (Q50333986) (← links)
- N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney. (Q50950478) (← links)
- Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study. (Q51823157) (← links)
- Factors predicting erythropoietin resistance among maintenance hemodialysis patients. (Q53653496) (← links)
- Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits. (Q54617646) (← links)
- The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage. (Q55506594) (← links)
- High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial (Q57389527) (← links)
- Effectiveness of long-term using statins in COPD - a network meta-analysis (Q61445076) (← links)